|
PD-1 and PD-L1 inhibitor Clinical Trials
1 actively recruiting trial
Top Sponsors
- Tianjin Medical University Cancer Institute and Hospital1
Indications
- Serum Ferritin1
- Immune-related Adverse Event1
- Malignant Solid Tumors1
- Acute Leukemia1
- Cancer1
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.